This review describes the impact of nonmedical switching of biologic therapies on US patients and providers, with a focus on switching to in-class alternatives.
Sharon Phares, PhD, MPH
Advertisement
Articles by Sharon Phares, PhD, MPH
Advertisement
Latest Updated Articles
- Perspectives on Nonmedical Switching and the COVID-19 Pandemic: A Narrative Review
Published: September 26th 2022 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
Teclistamab for R/R MM Effective and Safe When Administered in a Community Setting
3
Near Low–Income Medicare Beneficiaries Face More Affordability Problems Than Other Income Groups
4
Childhood Insurance Dynamics Predict Medicaid Cuts Will Widen Gaps
5
